Update on ALS research Prof. Ole-Bjørn Tysnes Dept of Neurology Haukeland University Hospital.

Slides:



Advertisements
Similar presentations
Amyotrophic Lateral Sclerosis (ALS)
Advertisements

ALS Research Yesterday, Today and Tomorrow Heather D. Durham, PhD.
Motor neuron disease What are motor neuron diseases? Who is at risk? What are the causes motor neuron diseases? How are they classified? What are the symptoms.
Frontotemporal Dementia
Genetic Modified Cell Therapy for Amyotrophic Lateral Sclerosis (ALS) Tianyi Cai PBIO /02/2014.
Diagnosis of motor neuron disease Pille Taba, Karin Rallmann University of Tartu VI Nordic ALS Alliance Meeting Aug 21, 2010 Haapsalu, Estonia.
ALS By Arjun Puri and Navdeep Saini. Intro Amyotrophic Lateral Sclerosis Neurodegenerative disease Incurable and fatal Can affect anyone Life expectancy.
Duchenne Muscular Dystrophy
Comparing the Toxicity of Zinc Deficient Superoxide Dismutase (SOD) and the Quad SOD mutant: Implications for Amyotrophic Lateral Sclerosis Jesse Fitzpatrick.
Motor Neurone Disease Different types & Life Expectancy
Amyotrophic Lateral Sclerosis (ALS)
ALS Kate Crain. Amyotrophic Lateral Sclerosis Lou Gehrig Disease Charcot’s Syndrome.
Investigation of mutated Cu/Zn Superoxide Dismutase Sam Schuberg Beckman Laboratory Howard Hughes Medical Institute: Summer 2007.
Part I Mr. Robert Middelton … Over the past few years, he noticed...a slowly developing weakness initially in his hands and arms, now spreading to his.
Amyotrophic Lateral Sclerosis (ALS) Sarah Belair and Hannah McLaughlin.
Multiple Sclerosis Abdulelah Nuqali Intern. DemyelinationCNSAquired Multiple Sclerosis Optic neuritis Acute Disseminated Encephalomyelitis Hereditary.
NEUROLOGICAL DISORDERS. Dementia  A degenerative syndrome characterized by deficits in memory, language, and mood.  The most common form: Alzheimer’s.
Lou Gehrig's Disease By: Brittany Harden.
Amyotrophic lateral sclerosis (ALS). What is amyotrophic lateral sclerosis? It is a progressive neurological disease that affects the control of muscle.
By Intracerebroventricular Delivery of VEGF in a Rat Model of ALSEGF in a Rat Model of ALS Treatment of Motoneuron Degeneration.
Neurodegeneration is the umbrella term for the progressive loss of structure or function of neurons, including death of neurons. Many neurodegenerative.
PATRICK CASEY FALL 2007 PARAMEDIC CLASS Amyotrophic Lateral Sclerosis.
Amyotrophic Lateral Sclerosis
Amyotrophic Lateral Sclerosis and Superoxide Dimutase 1 (SOD1) Iasson Yi CHEM 4700.
MS: A Perspective on the African American Experience Mary D. Hughes, MD Medical Director, Neuroscience Associates University Medical Group Greenville Hospital.
LOU GEHRIG’S DISEASE.  Also known as Amyotrophic Lateral Sclerosis  Is a disease of the nerve cells in the brain and spinal cord that control voluntary.
Motor neuron disease Dr.Shamekh M. El-Shamy.
REFERENCES 1. Karitzky J, Ludolph AC. Imaging and neurochemical markers for diagnosis and disease progression in ALS. Journal of the Neurological Sciences.
Effect of alternative metabolic fuels as a potential ALS therapy in mice and humans Csilla Ari, Craig R. Goldhagen, Angela Poff, Heather Held, Carol Landon,
Lou Gehrig’s Disease. - Jean-Martin Charcot discovered Men most affected - Still remains mostly a mystery.
Amyotrophic Lateral Sclerosis (ALS)
ALZHIEMERS DISEASE IN UK ‘’The Dementia Time bomb’’ By VISHAL ZAVERI AND ORE AJAI.
Molecular Biology and Genetics of Amyotrophic Lateral Sclerosis Michael Sidel February 13, 2008.
Amyotrophic Lateral Sclerosis. Motor Neuron Disease Terminology Lower motor neuron Upper motor neuron Progressive Muscular Atrophy Amyotrophic Lateral.
ALS by Cheetahs.  Güldeniz Karakuş  Abide Yıldız  Zeynep Özal  Esra Akman.
漸凍症 amyotrophic lateral sclerosis. Lou Gehrig's disease 1939 Jean-Martin Charcot Amyotrophic lateral sclerosis (ALS) (Rosen DR et al. Nature 1993) 1869.
47-year-old with progressive upper limb weakness Teaching NeuroImages Neurology Resident and Fellow Section © 2014 American Academy of Neurology.
NEUROLOGICAL DISORDERS. Dementia  A degenerative syndrome characterized by deficits in memory, language, and mood.  The most common form: Alzheimer’s.
Patient #5 ALS. Patient Background and Problems Patient #5- Andrew, a 45 year-old single father of two, comes to you in confidence. He’s noticed that.
By TJ Wittmer Muscle weakness. Slurred speech. Also it is very difficult swallow.
Electromyography Tatiana Steinwarz.
06/23/2002 RECENT ADVANCES IN TREATING POST-POLIO SYNDROME Susan L. Perlman, M.D. Associate Professor of Neurology UCLA Medical Center.
ALS: Amyotrophic Lateral Sclerosis Lou Gehrig’s Disease.
Neurological Disorders
PATIENT #5: ANDREW Ashton Crowe Rayvin Ewers Miranda McCormick.
Amyotrophic Lateral Sclerosis (ALS)
ALS Samuel Awad & Osama Jamali. Introduction ALS is one of the most common neuromuscular diseases worldwide, and people of all races and ethnic backgrounds.
ALS and Neuromuscular Diseases in Latvia Viktorija Ķēniņa M.D., Ph.D Neuroimmunologist at P. Stradins Clinical University Hospital.
Amyotrophic Lateral Sclerosis
Motor neuron disease.
Human Genetic Disorders Every cell in the human body has 46 chromosomes except for gametes, egg sperm cells, which contain 23 or the haploid number. Human.
MYASTHENIA GRAVIS Aswad H. Al.Obeidy FICMS, FICMS GE&Hep Kirkuk General Hospital.
Pathogenesis and pathology of parkinsonism
Tay Sachs Disease Linda Lu. What is Tay Sachs Disease? - A rare genetic disorder that destroys neurons in the brain and the spinal cord - Results from.
STEM CELL RESEARCH ON HUNTINGTON’S DISEASE Josh Merrifield, Michael Jennings, and Stephanie Antone.
Used to be called Dementia Neurocognitive Disorders.
By: Roman Amyotrophic Lateral Sclerosis (ALS) is also known as Lou Gehrig's disease.
Amyotrophic Lateral Sclerosis (ALS). Also know as Lou Gehrig's Disease Named after the New York Yankees baseball star who played first base and was diagnosed.
AMERICAN PHYSIOLOGICAL SOCIETY EDUCATION COMMITTEE Refresher Course 2002: Recent Advances in Neuroscience Stem Cells, Growth Factors and Neurodegeneration.
ZOO405 by Rania Baleela is licensed under a Creative Commons Attribution- NonCommercial-ShareAlike 3.0 Unported LicenseRania BaleelaCreative Commons Attribution-
Frontotemporal Lobar Degeneration:
Diagnosing MND: what I say to patients and their families
Amyotrophic Lateral Sclerosis (ALS)
Ashton Crowe Rayvin Ewers Miranda McCormick
Amyotrophic Lateral Sclerosis (ALS)
Amyotrophic Lateral Sclerosis
What does this protein make up or do? amyotrophic lateral sclerosis
Respiratory Management in MND
Respiratory Management in MND
Disease of the Central Nervous System By Eric Nauman
Presentation transcript:

Update on ALS research Prof. Ole-Bjørn Tysnes Dept of Neurology Haukeland University Hospital

What is ALS? Clinical characteristicsClinical characteristics Pathological findingsPathological findings Genetics in ALSGenetics in ALS

Clinical characteristics May start with symptoms like speech or swallowing difficulties (bulbar ALS)May start with symptoms like speech or swallowing difficulties (bulbar ALS) Most frequently start as progressive weakness in a limb (classic ALS)Most frequently start as progressive weakness in a limb (classic ALS) Fasciculations frequently apparentFasciculations frequently apparent Slightly more frequent in men than womenSlightly more frequent in men than women Annual incidence 2/ per yearAnnual incidence 2/ per year

EMG essential to ensure the diagnosisEMG essential to ensure the diagnosis Important differential diagnoses must always be consideredImportant differential diagnoses must always be considered –Cervical radiculomyelopathy –Post polio syndrome –Motor neuropathies Conditions with gammopathiesConditions with gammopathies Diabetic amyotrophyDiabetic amyotrophy –Myasthenia gravis

ALS is a serious and gradually progressive diseaseALS is a serious and gradually progressive disease Survival time may however vary considerablySurvival time may however vary considerably Involve all muscles of the body with timeInvolve all muscles of the body with time Eye muscles are only affected very lateEye muscles are only affected very late Mental symptoms may occur during the course of the diseaseMental symptoms may occur during the course of the disease

Pathological characteristics Loss of motor neurons in the spinal cordLoss of motor neurons in the spinal cord Diffuse sclerosis of the spinal cordDiffuse sclerosis of the spinal cord

Genetics in ALS Most ALS cases (more than 90%) are sporadicMost ALS cases (more than 90%) are sporadic If inherited (less than 10%) almost all cases are autosominal dominant (present in every generation)If inherited (less than 10%) almost all cases are autosominal dominant (present in every generation) 20% of the inherited cases are related to mutations in SOD (superoxide dismutase)20% of the inherited cases are related to mutations in SOD (superoxide dismutase) Mutations other than SOD are very rare in ALSMutations other than SOD are very rare in ALS

On this background: Where do we stand in ALS research? Epidemiologic researchEpidemiologic research Genetic researchGenetic research Disease modifying treatment in ALSDisease modifying treatment in ALS –In ALS models –In patients (treatment trials) Stem cellsStem cells ALS managementALS management

Update on epidemiologic research Increase in ALS?Increase in ALS? Environmental factors?Environmental factors? Increased risk in Gulf war veterans and professional football players?Increased risk in Gulf war veterans and professional football players? Mental symptoms in ALS?Mental symptoms in ALS?

Increase in incidence of ALS? Seljeseth et al 2000

Traynor el al 2007 Stable incidence in Ireland during the last 7 years Annual incidence 2.5/ /Y ALS slightly more frequent in men than women Decrease in ALS incidence in the oldest age groups

Environmental risk factors in ALS? OB Tysnes, ACNR, 2004

Chio et al, Brain, 2005: Severely increased risk of ALS among Italian professional football players

Wicks et al, Amyotrophic Lateral Sclerosis, 2007: Three soccer playing friends with simultaneous amyotrophic lateral sclerosis

Armon 2007, J Neurol Sci Most likely not increased risk of ALS in football players

Mental tests that are independent of motor perfomance Conclusion: 50% of ALS patients have significant but small mental deficits 15% of ALS patients fullfil criteria of Frontotemporal dementia

Update on genetic research Mutations related to ALSMutations related to ALS Diversity in the impact of SOD mutationsDiversity in the impact of SOD mutations Genetic variants with ALS and dementiaGenetic variants with ALS and dementia

Strange et al, PNAS, 2007 More than 100 mutations in SOD1 can cause ALS Loss of Zn molecules in SOD destabilises the molecule This will with time lead to aggregation of SOD1 molecules Such aggregation may preceede neuronal death

Peter Andersen (Umeå): Different SOD mutations give variable phenotype in ALS Age of onset vary considerable within the same mutation Disease duration short in som familial ALS and long in others

ALS Bulb. ALSSpinal ALSSpinal ALSFTD Are ALS and Frontotemporal dementia linked? Norwegian ALS/FTD family

Spina et al, Neurology 2007 FTD and ALS may be linked to mutations in progranuline, but other genetic causes are likely to occur

Update on disease modifying treatment In ALS animal modelsIn ALS animal models –By the use of drugs –By genetic modelling In patients (treatment trials)In patients (treatment trials) –Oral drugs –Infusion therapies

Jung et al, Neurosci Lett, 2001 Antioxidant therapy (EUK-8 and EUK-134) increase survival in SOD mice.

Pompl et al, FASEB journal 2003: Cox2 inhibition delays progression of disease in SOD Mice

Ermilova et al, Neurosci lett 2005 Effects of Zn in the diet on survival of SOD transgenic mice.

Marden et al, J Clin Invest, 2007 Genetic treatment of SOD mice by inhibition of NAPDH oxidases Nox 1 and Nox 2 (knock outs) Problem: Lethal eye infection in cases of the NOX 2 knock outs

Use of stem cells: Charlatans or any evidence of effect? ALS animal modelsALS animal models Humans: Latest news from EFNSHumans: Latest news from EFNS

Suzuki et al, PNOS1 2007: Implanted GDNF secreting human progenitor cells make motor neurons survive, but do not prolong survival in SOD mice Motor neuron survival

Suzuki et al 2007Survival

Habisch et al, J Neural Trans, 2007 Injection of neural stem cells in the cisterna magna did not prolong survival of SOD mice Question from the authors: Too few cells transplanted?

Miller et al, Neurology, 2007 No effect of antiapoptotic treatment (TCH346) in ALS

Giordano et al, Cell Physiol, 2007 No effect of any stem cell therapy to day Several serious adverse events, even lethal. Most frequent are infections and allergic reactions

EFNS August The price for intrathecal stem cell therapy is $ and its currently given in Russia and China - They claim 6 months increased survival - No data on efficacy has been provided Conclusion: - Current clinical stem cell treatment in ALS is run by charlatans

ALS management Neppelberg et al, Eur J Neurol, 2007 Radiotherapy significantly reduces sialorrhea in ALS

Neppelberg et al, Eur J Neurol, 2007 Patient are satisfied with the effect of radiotherapy on sialorrhea.

Is training bad for ALS patients? Liebetanz et al, J Neurol Sci, 2004: No differences in strength evolotion or survival in SOD mice between sedentary, control and actively trained mice. A tendency that the trained group survived longer

Bello-Haas et al, Neurology, 2007 ALS patients in careful training had better ALS Functional Rating Score at the end of the study

Conclusions Very much ALS research is performedVery much ALS research is performed No breakthrough has been done on treatmentNo breakthrough has been done on treatment Extensive research on basic pathology in ALS may open up new possibilitiesExtensive research on basic pathology in ALS may open up new possibilities Clinical research on ALS management give better possibilities of dealing with problems that occur during the course of the diseaseClinical research on ALS management give better possibilities of dealing with problems that occur during the course of the disease